Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 8, 2011

Primary Completion Date

April 17, 2025

Study Completion Date

April 17, 2025

Conditions
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Interventions
BEHAVIORAL

geriatric assessment and telephone call from nurse

The geriatric assessment will be completed at four time points: 1) on the day the patient receives a new chemotherapy regimen or within 30 days prior, 2) within 30 days of completion of the chemotherapy regimen (or at 12 months from study entry +/-30 days if the chemotherapy regimen is still being continued), 3) within 30 days prior to surgical debulking, and 4) 30 days after surgical debulking. The patient will receive a phone call once a week by a nurse who is an expert in caring for older patients. He/she will be asking questions about symptoms, medications and support at home. Each call is designed to last less than 30 minutes.

OTHER

geriatric assessment and no call from nurse

The geriatric assessment will be completed at four time points: 1) on the day the patient receives a new chemotherapy regimen or within 30 days prior, 2) within 30 days of completion of the chemotherapy regimen (or at 12 months from study entry +/-30 days if the chemotherapy regimen is still being continued), 3) within 30 days prior to surgical debulking, and 4) 30 days after surgical debulking. They will not receive the phone calls, questions and symptoms will be addressed directly by the doctors and nurses on the medical and surgical teams.

Trial Locations (3)

10065

Memorial Sloan-Kettering Cancer Center, New York

11725

Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack

Memorial Sloan-Kettering Cancer Center at Commack, Commack

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT01471483 - Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer | Biotech Hunter | Biotech Hunter